Medtech Acquisition Corp Probability of Future Stock Price Finishing Over 9.86
| MTACUDelisted Stock | USD 9.86 0.00 0.00% |
Medtech |
Medtech Acquisition Target Price Odds to finish over 9.86
The tendency of Medtech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 9.86 | 90 days | 9.86 | about 98.0 |
Based on a normal probability distribution, the odds of Medtech Acquisition to move above the current price in 90 days from now is about 98.0 (This Medtech Acquisition Corp probability density function shows the probability of Medtech Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Medtech Acquisition Corp has a beta of -0.38. This indicates as returns on the benchmark increase, returns on holding Medtech Acquisition are expected to decrease at a much lower rate. During a bear market, however, Medtech Acquisition Corp is likely to outperform the market. Additionally Medtech Acquisition Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Medtech Acquisition Price Density |
| Price |
Predictive Modules for Medtech Acquisition
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medtech Acquisition Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medtech Acquisition's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medtech Acquisition Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Medtech Acquisition is not an exception. The market had few large corrections towards the Medtech Acquisition's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medtech Acquisition Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medtech Acquisition within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.03 | |
β | Beta against Dow Jones | -0.38 | |
σ | Overall volatility | 0.17 | |
Ir | Information ratio | -0.38 |
Medtech Acquisition Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medtech Acquisition for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medtech Acquisition Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Medtech Acquisition is not yet fully synchronised with the market data | |
| Medtech Acquisition has a very high chance of going through financial distress in the upcoming years | |
| Medtech Acquisition Corp has accumulated 2.37 M in total debt with debt to equity ratio (D/E) of 1.77, which is about average as compared to similar companies. Medtech Acquisition Corp has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Medtech Acquisition's use of debt, we should always consider it together with its cash and equity. | |
| Medtech Acquisition Corp has accumulated about 69.18 K in cash with (2.74 M) of positive cash flow from operations. |
Medtech Acquisition Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medtech Stock often depends not only on the future outlook of the current and potential Medtech Acquisition's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medtech Acquisition's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31.2 M | |
| Cash And Short Term Investments | 153.6 K |
Medtech Acquisition Technical Analysis
Medtech Acquisition's future price can be derived by breaking down and analyzing its technical indicators over time. Medtech Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Medtech Acquisition Corp. In general, you should focus on analyzing Medtech Stock price patterns and their correlations with different microeconomic environments and drivers.
Medtech Acquisition Predictive Forecast Models
Medtech Acquisition's time-series forecasting models is one of many Medtech Acquisition's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Medtech Acquisition's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Medtech Acquisition Corp
Checking the ongoing alerts about Medtech Acquisition for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Medtech Acquisition Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Medtech Acquisition is not yet fully synchronised with the market data | |
| Medtech Acquisition has a very high chance of going through financial distress in the upcoming years | |
| Medtech Acquisition Corp has accumulated 2.37 M in total debt with debt to equity ratio (D/E) of 1.77, which is about average as compared to similar companies. Medtech Acquisition Corp has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Medtech Acquisition's use of debt, we should always consider it together with its cash and equity. | |
| Medtech Acquisition Corp has accumulated about 69.18 K in cash with (2.74 M) of positive cash flow from operations. |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Medtech Stock
If you are still planning to invest in Medtech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medtech Acquisition's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |